Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation

Author(s):: Janssen, M.T.H.F.; Ramiro, S.; Landewe, R.B.M.; Magro-Checa, C.; Mostard, R.L.M.

Published: 2021
Publication type: Article / Letter to editor

Date issued: 2021-10-01
Language: English
Publisher: BMJ PUBLISHING GROUP
Is part of
hdl: 1887/3240264
doi: 10.1136/annrheumdis-2021-220040
URL: https://ard.bmj.com/content/annrheumdis/80/10/1362.full.pdf